Marina Chiara Garassino
Department of Medicine
Marina Chiara Garassino is an internationally recognized expert in the treatment of thoracic malignancies, whose research emphasis is on precision medicine and immuno-oncology, as well as the development of new drugs and therapeutic strategies and biomarkers. Previously, she directed the Thoracic Medical Oncology Unit at one of the most renowned comprehensive cancer centers in Europe, the Fondazione IRCCS Istituto Nazionale dei Tumori in Milan, and led clinical and translational research in advanced and locally advanced non-small cell lung cancer, mesothelioma, thymoma, and thymic carcinoma.
Garassino is actively involved in the international oncology community, including the European Society for Medical Oncology. In response to the COVID-19 pandemic, she brought together and established an international group of physicians and investigators to study its impact on patients with lung cancer. This led to the initiation of the Thoracic Cancers International COVID-19 Collaboration (TERAVOLT), a global registry for patients with thoracic cancers who are infected with the COVID-19 virus. Data from this consortium have been published in The Lancet Oncology and Cancer Cell.
She received her medical degree from the Università degli Studi di Milano in Italy, where she also completed her training in medical oncology. After a fellowship at the Christie Hospital in Manchester, United Kingdom, she served as a physician oncologist at cancer centers in Italy.